GlobeStar Therapeutics Corp (GSTC)

[stervc]

StaleyCornell, important to understand here with SOAN...

SOAN is in Phase III (Phase 3) with their Clinical Trials for their Liprostin™ drug for treating intermittent claudication and FDA news is due any day regarding such.

Phase III studies are tightly controlled, double-blind studies with a sample size of at least 1000 patients or less if approved by the FDA like how SOAN was approved to do. They were approved by the FDA to conduct their Phase III Clinical Trials with 120+ patients. In my opinion, that is a huge show of confidence in the SOAN drug by the FDA. At this point, the drug has better than a 70% chance of being approved by the FDA.

After Phase III is the positioning for Revenues to where SOAN is getting closer to being able to implement. This is huge in my opinion.

SOAN is using a drug within their Liprostin™ drug that was already approved by the FDA. That drug is called Alprostadil that SOAN is using in their drug. So, I like our odds of SOAN getting their Liprostin™ drug approved by the FDA since it also had awesome Phase II results within its Clinical Trials and proven to work 4 times faster and is more than twice as effective than the already FDA approved drug called Cilostazol™ that is helping CASI Pharmaceuticals Inc. to generate significant revenues which trades on the NASDAQ under the ticker of CASI between the $5.00 to $6.00 per share range.

For inquiring minds, CASI bought their already FDA approved drug called Cilostazol™ from another company which is why I think it is fair to believe that SOAN could very likely be a buyout candidate too.

v/r
Sterling